- Home
- /
- Treatment
- /
- Page 15
Treatments
The following database contains products that have been granted orphan status, or have been market approval in the EU or the USA.
You can filter the content by clicking on the titles: Product, Indication, Sponsor and Date. Clicking once, will filter the column alphabetically from A – Z and a second click on the same title will filter from Z – A.
Become a Partner.
Country | Product | Indication | Sponsor | Date |
---|---|---|---|---|
Adeno-associated viral vector serotype rh.10 expressing beta-galactosidase | Gangliosidosis generalized GM1- type 1 | LYSOGENE | March 20, 2017 | |
Allogeneic ex-vivo-expanded umbilical cord blood-derived hematopoietic CD34+ progenitor cells and allogeneic non-expanded umbilical cord blood-derived hematopoietic mature myeloid and lymphoid cells | Treatment in haematopoietic stem cell transplantation | Regulatory Resources Group Ltd | March 20, 2017 | |
Autologous adipose tissue-derived mesenchymal stem cells | Buerger’s disease | SPC GmbH | March 20, 2017 | |
Antisense oligonucleotide targeting theUSH2Agene | Retinitis pigmentosa | ProQR Therapeutics IV BV | March 20, 2017 | |
1-(2-chlorophenyl)-1-(S)-hydroxy-2-(S)-carbamoyloxy-propane | West syndrome | Bio-Pharm Solutions, Co., Ltd.;6F, C Bldg., Advanced Institute of Convergence Technology, 145 Gwanggyo-Ro, Yeongtong-Gu;Suwon | March 20, 2017 | |
Phosphoinositide 3-kinase gamma peptide | Cystic fibrosis | Kither Biotech s.r.l. | March 20, 2017 | |
Cannabidiol | Lennox-Gastaut syndrome | GW Research Ltd | March 20, 2017 | |
Cell-penetrating dominant-negative activating transcription factor 5 | Glioma | Sapience Therapeutics, Inc;500 Mamaroneck Avenue, Suite 320;Harrison, New York, 10528 | March 20, 2017 | |
Poly-cyclodextrin-bis-cysteine-PEG3400-camptothecin-conjugate | Ovarian cancer | Viadoc Business Solutions Limited | March 20, 2017 | |
Liposomal annamycin | Acute myeloid leukemia | Moleculin Biotech, Inc.;2575 West Bellfort Avenue, Suite 333;Houston, Texas, 77054 | March 20, 2017 | |
Inebilizumab | Neuromyelitis optica | AstraZeneca AB | March 20, 2017 | |
N-(3-(4-(3-(diisobutylamino)propyl)piperazin-1-yl)propyl)-1H-benzo[d]imidazol-2-amine disulphate salt | Progressive supranuclear palsy | Alzprotect sas;70 rue du docteur Alexandre Yersin;Loos | March 20, 2017 | |
Ketoconazole | Granulosa cell tumours | Grupo Español de Tumores Huérfanos e Infrecuentes (GETHI) | March 20, 2017 | |
(3’R,4’S,5’R)-N-[(3R,6S)-6-carbamoyltetrahydro-2H-pyran-3-yl]-6”-chloro-4′-(2-chloro-3-fluoropyridin-4-yl)-4,4-dimethyl-2”-oxo-1”,2”-dihydrodispiro[cyclohexane-1,2′-pyrrolidine-3′,3”-indole]-5′-carboxamide mono(4-methylbenzenesulfonate) monohydrate | Soft tissue sarcoma | Daiichi Sankyo Europe GmbH | March 20, 2017 | |
Megestrol acetate | Granulosa cell tumours | Grupo Español de Tumores Huérfanos e Infrecuentes (GETHI) | March 20, 2017 | |
Talabostat | Stages IIb through IV melanoma | BioXcel Corporation;780 East Main Street, Suite 2;Branford, Connecticut, 06405 | March 20, 2017 | |
Adeno-associated viral vector serotype 8 containing the human alpha-galactosidase A gene | Fabry disease | Freeline Therapeutics Ltd | March 20, 2017 | |
Pentetrazol | Narcolepsy | Balance Therapeutics, Inc.;1250 Bayhill Drive, Suite 125;San Bruno, California, 94066 | March 16, 2017 | |
Recombinant human placental growth factor | Severe preeclampsia | Aggamin, LLC;3960 Broadway, Suite 330B;New York, New York, 10032 | March 16, 2017 | |
Synthetic, single stranded, fully phosphorothioated 2’-OMethyl-RNA and DNA mixmer oligonucleotide-based compound targeted against natural antisense transcripts (NATs) | Dravet Syndrome | OPKO Ireland Global Holdings Ltd.;10 Market Street, Suite 721;Camana Bay | March 16, 2017 | |
Mutated form of human acetylcholine receptor a1 extracellular domain subunit | Myasthenia gravis Myasthenia gravis | Toleranzia AB;Arvid Wallgrens backe 20;Gothenburg | March 16, 2017 | |
Synthetic, single stranded, fully phosphorothioated 2�-OMethyl-RNA and DNA mixmer oligonucleotide-based compound targeted against natural antisense transcripts (NATs) | Dravet Syndrome | OPKO Ireland Global Holdings Ltd.;10 Market Street, Suite 721;Camana Bay | March 16, 2017 | |
Talabostat | Pancreatic Cancer | BioXcel Corporation;780 East Main Street, Suite 2;Branford, Connecticut, 06405 | March 16, 2017 | |
Activated natural killer[aNK]) | Merkel cell cancer | NantKwest, Inc.;9920 Jefferson Boulevard;Culver City, California, 90232 | March 15, 2017 | |
Fixed dose combination of methimazole and liothyronine | Brain metastases in patients with primary lung cancer | Musli Thyropeutics Ltd.;6 Hagefen Street, P. O. Box 529;Zur Moshe | March 6, 2017 |